BATS

Enzo Villani, Financial Markets Strategist Joins Alvara Protocol as a Key Advisor

Retrieved on: 
Wednesday, February 7, 2024

Enzo Villani, CEO, Alpha Transform Holdings, stated, “Alvara introduces a unique protocol that decentralizes fund management with transparency and efficiency at its core.

Key Points: 
  • Enzo Villani, CEO, Alpha Transform Holdings, stated, “Alvara introduces a unique protocol that decentralizes fund management with transparency and efficiency at its core.
  • Alvara addresses these challenges with an integrated approach, streamlining the entire fund management experience.”
    Callum Mitchell-Clark , Co-Founder, stated, "With his unparalleled experience as Chief Strategist at OKX and Nasdaq Corporate Solutions, Enzo brings a wealth of knowledge to the Alvara team.
  • Dominic Ryder , Co-Founder, stated, “Alvara has the potential to be one of the most scalable pieces of DeFi infrastructure crypto has ever seen.
  • Enzo's experience and guidance will be invaluable in pushing this groundbreaking technology to the world.”

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, February 1, 2024

Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the Company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, November 2, 2023

Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the Company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

SHAREHOLDER ALERT: Lowey Dannenberg is Investigating Cboe Global Markets, Inc. for Potential Breaches of Fiduciary Duty by Its Board of Directors

Retrieved on: 
Thursday, October 12, 2023

NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Cboe Global Markets, Inc. (“Cboe” or the “Company”) (BATS: CBOE).

Key Points: 
  • NEW YORK, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Cboe Global Markets, Inc. (“Cboe” or the “Company”) (BATS: CBOE).
  • If you are a shareholder of Cboe and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact Andrea Farah via email at [email protected] or at (914) 733-7256 or Alesandra Greco at [email protected] or (914) 733-7272.

SHAREHOLDER ALERT: Lowey Dannenberg is Investigating Cboe Global Markets, Inc. for Potential Breaches of Fiduciary Duty by Its Board of Directors

Retrieved on: 
Monday, September 25, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Cboe Global Markets, Inc. (“Cboe” or the “Company”) (BATS: CBOE).

Key Points: 
  • NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Cboe Global Markets, Inc. (“Cboe” or the “Company”) (BATS: CBOE).
  • If you are a shareholder of Cboe and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact Andrea Farah via email at [email protected] or at (914) 733-7256 or Alesandra Greco at [email protected] or (914) 733-7272.

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, July 27, 2023

Shell plc (the ‘Company’) today announces the commencement of a $3 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘Company’) today announces the commencement of a $3 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the Company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, May 4, 2023

Shell plc (the ‘company’) today announces the commencement of a $4 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘company’) today announces the commencement of a $4 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

Shell announces commencement of a share buyback programme

Retrieved on: 
Thursday, February 2, 2023

Shell plc (the ‘company’) today announces the commencement of a $4 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).

Key Points: 
  • Shell plc (the ‘company’) today announces the commencement of a $4 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’).
  • The purpose of the programme is to reduce the issued share capital of the company.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

EQS-News: CBOE's Weekly Market Recap: Nov.14-18 – Biogen’s Alzheimer’s Drug Captures Investors’ Attention

Retrieved on: 
Sunday, November 27, 2022

With uncertainty brimming, Cboe highlights Biogen Inc. (NASDAQ: BIIB) as a chart that may have piqued investor interest following positive clinical trial results for their new Alzheimers drug.

Key Points: 
  • With uncertainty brimming, Cboe highlights Biogen Inc. (NASDAQ: BIIB) as a chart that may have piqued investor interest following positive clinical trial results for their new Alzheimers drug.
  • Cboe has compiled a list of earnings for investors to keep an eye on at the bottom of this report.
  • Shares of Biogen skyrocketed on Sept. 22nd after the company announced positive clinical trial results for their Alzheimers drug lecanemab.
  • These results have brought Biogen closer to a Federal Drug Agency (FDA) approved Alzheimers drug, a feat several biopharmaceutical companies are competing to achieve.

EQS-News: Welcoming Earnings Season – CBOE's Weekly Market Recap: Oct. 10-14

Retrieved on: 
Friday, October 28, 2022

Welcoming Earnings Season CBOE's Weekly Market Recap: Oct. 10-14

Key Points: 
  • Welcoming Earnings Season CBOE's Weekly Market Recap: Oct. 10-14
    The issuer is solely responsible for the content of this announcement.
  • High levels of uncertainty crept into last weeks market movements, causing whipsawing price action across the board.
  • Currently, the CPI sits 8.2% higher than a year ago, reflecting inflations painful resilience to the Feds countermeasures.
  • Cboe has compiled a list of earnings for investors to keep an eye on at the bottom of this report.